An Open Randomized Control Clinical Trial TO Evaluate The Efficacy Of Aragvadhadi Kwath Yonidhavan In Kaphaj Yonivyapad With Special Reference To Vulvovaginal Candidiasis
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 64
- Locations
- 1
Study Overview
Brief Summary
In Ayurveda, a dedicated section on women’s health uses the term Yoni vyapad to encompass most gynecological disorder. 20 Yonirogas (Vinshati Yonivyapad) described in Ayurveda samhita by different Acharyas. Kaphaj Yonivyapad is one among them having Yonigata Shwetstrav, Yoni kandu and alpa yonivedana as Pradhan lakshan.
Vulvovaginal candidiasis (VVC), one of the most widespread fungal infections among women of reproductive age, is most often caused by Candida albicans. In India, an estimated 30% of women have vaginal candidiasis. It is characterized by symptoms like vaginal itching, white curd-like discharge, erythema and discomfort, significantly impacting the quality of life. Most antifungal regimen treatments are available for vaginal candidiasis can but have chance of side effects as well as recurrences.
The drug Aragvadha, Nimb & karanj having properties Kaphashamak, Kandughana, Krimighana, Stambhak Vranaropak, Antiseptic. Because of these properties it helps to overcome the symptoms of Kaphaj Yonivyapad by increasing local immunity and prevent recurrence of symptoms in patients.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- None
Eligibility Criteria
- Ages
- 20.00 Year(s) to 50.00 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •Married Patients having Kaphaj Yonivyapad i.e having following signs and symptoms
- •Yonigata shweta picchil strav, Yoni kandu Yonigat alpavedana
- •Patient selection of vaginal candidiasis will be confirmed after doing KOH Test.
Exclusion Criteria
- •Unmarried female patients.
- •Known cases of sexually transmitted diseases.
- •Uncontrolled DM & HTN.
- •Pregnant women.
- •Cervical polyp and cervical erosion.
- •Patients with intolerable severe pain (VAS scale of 8 to 10) will be excluded.
Investigators
Dr Rahila Nawsheen Afsar Khan
Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Centre Ashta